KLAC vs LTRN · P/E 55, rev $13.58B vs $35.1M cap
KLA Corporation (KLAC) versus Lantern Pharma Inc (LTRN) — a side-by-side from cached financials, not a winner call.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US. It is led by Richard P. Wallace.
Lantern Pharma Inc (LTRN) is a biotechnology company listed on US.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
LTRN does not have a complete income-statement cache yet.
KLAC currently screens at market cap $252.01B and trailing P/E 54.7. LTRN currently screens at market cap $35.1M.
Not investment advice. Open the KLAC and LTRN stock pages for the full models.
Not investment advice.